Sensex Today | Stock Market LIVE Updates: B&K Securities has maintained its ‘Buy’ rating with Target Price of Rs. 770 (CMP- Rs. 622) for Suven Pharmaceuticals as it expect revenue of the company to double at combined sales (Suven + Cohance) over the next four-five years. The company remains top mid-cap pick in brokerage firm’s universe.